Social media companies make big investments to increase people’s engagement with their platforms. They employ all manner of tactics and techniques to make us spend more time viewing their content. The reason is simple: The higher the engagement, the more advertising revenue they can generate. In the clinical trial space, enhancing the engagement of patients is an increasingly hot topic. While it’s encouraging to see it moving up the agenda, most efforts continue to miss the outcome that matters most: We need to keep patients in their trials until they complete the protocol.
Despite our collective efforts to improve clinical trial design, implement new trial technologies, and adopt greater patient centricity, being a patient in a clinical trial is rarely a great experience. Presently roughly 20% of all patients randomized into a trial will still fail to complete the study – and that’s a huge problem for study timelines, total study costs, and time to market for novel treatments.
What’s missing from current patient engagement efforts?
Occasionally, we lose sight of the “why” of patient engagement. We relegate “engagement” to alarms, reminders, and informational messages. It’s time to start realizing the full potential of patient centricity and patient engagement by creating and nurturing meaningful interactions – the kind that meets patients where they are and make it far easier for them to follow the protocol.
Having been in the ePRO and patient engagement space for over a decade, I am excited to see signs of a shift toward this purpose-driven patient engagement. Moreover, that shift was the primary reason I joined Datacubed Health, where we are 100% focused on improving clinical trials for patients.
The Datacubed Difference
Datacubed Health uses modern behavioral science and economics to create meaningful digital clinical trial solutions. Our patient engagement solutions support ePRO/eCOA, eConsent, case alerts (including geofencing), and medication adherence. For this reason, we intentionally design our solutions to help retain patients and improve their experience.
By combining meaningful science and patient engagement, we can improve trial experiences, leading to better compliance and higher retention. It is important to realize this can speed up the process of bringing treatments to market, improving people’s lives everywhere.
That’s a “why” we can all celebrate. Take a few minutes to see us in action and be inspired – watch this brief demo video now!